Zacks Research Upgrades Lifeward (NASDAQ:LFWD) to “Hold”

Lifeward (NASDAQ:LFWD) was upgraded by equities researchers at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued on Monday,Zacks.com reports.

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Lifeward in a research note on Friday, July 17th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Lifeward currently has an average rating of “Hold” and a consensus target price of $10.00.

Lifeward Trading Down 1.7%

Shares of NASDAQ:LFWD opened at $6.99 on Monday. The company has a market cap of $19.63 million, a P/E ratio of -0.36 and a beta of 0.37. The company has a debt-to-equity ratio of 1.16, a current ratio of 2.40 and a quick ratio of 1.82. Lifeward has a 1 year low of $4.14 and a 1 year high of $10.56. The stock’s fifty day moving average price is $7.39 and its 200-day moving average price is $7.05.

Lifeward (NASDAQ:LFWD) last released its quarterly earnings data on Friday, May 15th. The company reported ($6.70) EPS for the quarter, missing the consensus estimate of ($1.18) by ($5.52). Lifeward had a negative return on equity of 243.14% and a negative net margin of 123.66%.The business had revenue of $3.92 million during the quarter, compared to the consensus estimate of $5.78 million. Sell-side analysts expect that Lifeward will post -4.27 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Citadel Advisors LLC increased its position in shares of Lifeward by 1,271.8% during the 3rd quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after purchasing an additional 198,406 shares during the last quarter. HRT Financial LP boosted its holdings in shares of Lifeward by 149.7% in the fourth quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after buying an additional 29,423 shares during the last quarter. Jane Street Group LLC grew its position in Lifeward by 77.3% during the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock valued at $40,000 after buying an additional 29,927 shares during the period. Finally, Virtu Financial LLC grew its position in Lifeward by 158.0% during the fourth quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock valued at $35,000 after buying an additional 37,037 shares during the period. 26.76% of the stock is owned by hedge funds and other institutional investors.

About Lifeward

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.